Evidence map›Paper›PMID 38432607›Full record

ArticleOsteoarthritis and cartilage2024

Inhibition of Phlpp1 preserves the mechanical integrity of articular cartilage in a murine model of post-traumatic osteoarthritis.

Katherine M Arnold, Samantha R Weaver, Elizabeth L Zars, Daniel J Tschumperlin, Jennifer J Westendorf

Open access · bronzeAbstract read
In one paragraph

Article in Osteoarthritis and cartilage, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. PHLPP is neither a Phosphatase nor a Tumor Suppressor.BioEssays : news and reviews in molecular, cellular and developmental biology · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Katherine M ArnoldMayo Clinic Graduate School of Biomedical Sciences, Mayo Clinic, Rochester, MN, USA; Department of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, MN, USA; Department of Orthopedic Surgery, Mayo Clinic, Rochester, MN, USA. Electronic address: arnold.katherine@mayo.edu.
Samantha R WeaverDepartment of Orthopedic Surgery, Mayo Clinic, Rochester, MN, USA.
Elizabeth L ZarsDepartment of Orthopedic Surgery, Mayo Clinic, Rochester, MN, USA.
Daniel J TschumperlinDepartment of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, MN, USA.
Jennifer J WestendorfDepartment of Orthopedic Surgery, Mayo Clinic, Rochester, MN, USA; Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN, USA. Electronic address: westendorf.jennifer@mayo.edu.
Mayo Clinic in Arizona · USMayo Clinic · USMayo Clinic in Florida · US

Funding

Phlpp phosphatases in osteoarthritisR01AR078552 · NIAMS · MAYO CLINIC ROCHESTER · PI WESTENDORF, JENNIFER J · 2022 to 2025
$1.9M
Girk3 in bone biology and diseaseK99AR080745 · NIAMS · MAYO CLINIC ROCHESTER · PI WEAVER, SAMANTHA R · 2023 to 2024
$210k
NIAMS NIH HHS K99 AR080745NIAMS NIH HHS R01 AR078552
6 · The paper itself

Abstract

objectivePhlpp1 inhibition is a potential therapeutic strategy for cartilage regeneration and prevention of post-traumatic osteoarthritis (PTOA). To understand how Phlpp1 loss affects cartilage structure, cartilage elastic modulus was measured with atomic force microscopy (AFM) in male and female mice after injury.

methodsOsteoarthritis was induced in male and female Wildtype (WT) and Phlpp1

resultsMale WT mice showed decreased activity and histological signs of cartilage damage at 12 but not 6-weeks post-DMM. Female mice showed a less severe response to DMM by comparison, with no histological changes seen at any time point. In both sexes the elastic modulus of medial condylar cartilage was decreased in WT mice but not Phlpp1

conclusionsAFM is a sensitive method for detecting early changes in articular cartilage post-injury. Phlpp1 suppression, either through genetic deletion or pharmacological inhibition, protects cartilage degradation in a model of PTOA, validating Phlpp1 as a therapeutic target for PTOA.

Indexed as

Cartilage, ArticularPhosphoprotein PhosphatasesAnimalsDisease Models, AnimalElastic ModulusFemaleMaleMiceMice, KnockoutMicroscopy, Atomic ForceNuclear ProteinsOsteoarthritisOsteoarthritis, KneeTibial Meniscus InjuriesNuclear ProteinsPHLPP1 protein, mousePhosphoprotein PhosphatasesArticular cartilageAtomic force microscopyPrg4PTOA

Identifiers

PMID38432607
PMCPMC11127785
OpenAlexW4392388317

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.